Liver disease in hereditary hemorrhagic telangiectasia

Journal of Clinical Gastroenterology

Volumn 36, Issue 2, 2003, Pages 149-158

  Larson, Anne M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Arteriovenous malformations; Embolization; HHT; Liver; Liver transplantation; Telangiectasia hereditary hemorrhagic

Indexed keywords

ACTIVIN; ACTIVIN LIKE KINASE RECEPTOR 1; ENDOGLIN; RECEPTOR; UNCLASSIFIED DRUG;

ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; BILE DUCT DISEASE; BRAIN; CONGESTIVE HEART FAILURE; DYSPLASIA; GENE MUTATION; GENETIC HETEROGENEITY; HEPATIC ENCEPHALOPATHY; HIGH OUTPUT HEART FAILURE; HUMAN; ISCHEMIA; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG; MUCOSA; PHENOTYPE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SKIN; VISCERA;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER DISEASES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0037307998     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200302000-00013     Document Type: Review

References (182)

1. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987;82:989-97.
2. Plauchu H, de Chadarevian JP, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291-7.
3. Sutton HG. Familial Epistasix. Med Mirror (London) 1864;1:769-81.
4. Babington BG. Hereditary epistaxis. Lancet 1865;ii:362.
5. Rendu M. Epistasix répétés chez un sujet proteur de petis angiomies cutanes et muqueux. Bull Soc Med Hop Paris 1896;13:731.
6. Osler W. On a family with a form of recurring epistaxis associated with multiple telangiectases of the skin and mucous membrane. Bull Johns Hopkins Hosp 1901;12:333-7.
7. Weber F. Multiple hereditary developmental angiomata (telangiectasias) of the skin and mucous membranes associated with recurring hemorrhages. Lancet 1907;ii:160-2.
8. Hanes FM. Multiple hereditary telangiectasias causing hemorrhage (hereditary hemorrhagic telangiectasia). Bull Johns Hopkins Hosp 1909;20:63-73.
9. Heffner RR, Jr., Solitare GB. Hereditary hemorrhagic telangiectasia: neuropathologic observations. J Neurol Neurosurg Psychiatry 1969;32:604-8.
10. Karnik AM, Sughayer A, Fenech FF. Spontaneous haemothorax in Osler-Weber-Rendu disease. Postgrad Med J 1983;59:512-3.
11. Chu KM, Lai EC, Ng IO. Hereditary hemorrhagic telangiectasias involving the ampulla of Vater presented with recurrent gastrointestinal bleeding. Am J Gastroenterol 1993;88:1116-9.
12. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002;19:140-8.
13. McDonald MT, Papenberg KA, Ghosh S, et al. A disease locus for hereditary hemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet 1994;6:197-204.
14. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology 1986;91:1079-83.
15. Bideau A, Brunet G, Heyer E, et al. An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a genealogical and demographic study. Ann Hum Biol 1992;19:233-47.
16. Porteous ME, Burn J, Proctor SJ. Hereditary hemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992;29:527-30.
17. Jessurun GA, Kamphuis DJ, van der Zande FH, et al. Cerebral arteriovenous malformations in The Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg 1993;95:193-8.
18. Guttmacher AE, McKinnon WC, Upton MD. Hereditary hemorrhagic telangiectasia: a disorder in search of the genetics community. Am J Med Genet 1994;52:252-3.
19. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
20. Snyder LH, Doan LA. Is the homozygous form of multiple telangiectasia lethal? J Lab Clin Med 1944;29:1211-6.
21. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999;104:1343-51.
22. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-7.
23. Oh SP, Seki T, Goss KA, et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97[6], 2626-2631. 3-14-2000.
24. Arthur HM, Ure J, Smith AJ, et al. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000;217:42-53.
25. Cheifetz S, Bellon T, Cales C, et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992;267:19027-30.
26. Attisano L, Carcamo J, Ventura F, et al. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993;75:671-80.
27. ten Dijke P, Ichijo H, Franzen P, et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 1993;8:2879-87.
28. Lux A, Attisano L, Marchuk DA. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 1999;274:9984-92.
29. Shovlin CL, Letarte M. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714-29.
30. Piantanida M, Buscarini E, Dellavecchia C, et al. Hereditary hemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 1996;33:441-3.
31. Wallace GM, Shovlin CL. A hereditary hemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 2000;55:685-90.
32. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-8.
33. Pece-Barbara N, Cymerman U, Vera S, et al. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet 1999;8:2171-81.
34. Miyazono K, ten Dijke P, Ichijo H, et al. Receptors for transforming growth factor-beta. Adv Immunol 1994;55:181-220.
35. Attisano L, Wrana JL, Cheifetz S, et al. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 1992;68:97-108.
36. Paralkar VM, Vail AL, Grasser WA, et al. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 1998;273:13760-7.
37. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-91.
38. McCarthy SA, Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 1993;268:23066-71.
39. Madri JA, Bell L, Merwin JR. Modulation of vascular cell behavior by transforming growth factors beta. Mol Reprod Dev 1992;32:121-6.
40. Marchuk DA. The molecular genetics of hereditary hemorrhagic telangiectasia. Chest 1997;111:79S-82S.
41. Kretzschmar M, Massague J. SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev 1998;8:103-11.
42. Bourdeau A, Faughnan ME, Letarte M. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med 2000;10:279-85.
43. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-71.
44. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-beta receptor. Nature 1994;370:341-7.
45. Attisano L, Wrana JL, Montalvo E, et al. Activation of signaling by the activin receptor complex. Mol Cell Biol 1996;16:1066-73.
46. Nakao A, Imamura T, Souchelnytskyi S, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997;16:5353-62.
47. Botella LM, Sanchez-Elsner T, Rius C, et al. Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation. J Biol Chem 2001;276:34486-94.
48. Shovlin CL, Hughes JM, Tuddenham EG, et al. A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994;6:205-9.
49. Heutink P, Haitjema T, Breedveld GJ, et al. Linkage of hereditary hemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 1994;31:933-6.
50. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51.
51. Cymerman U, Vera S, Pece-Barbara N, et al. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 2000;47:24-35.
52. McAllister KA, Lennon F, Bowles-Biesecker B, et al. Genetic heterogeneity in hereditary hemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 1994;31:927-32.
53. Porteous ME, Curtis A, Williams O, et al. Genetic heterogeneity in hereditary hemorrhagic telangiectasia. J Med Genet 1994;31:925-6.
54. Marchuk DA, Guttmacher AE, Penner JA, et al. Report on the workshop on Hereditary Hemorrhagic Telangiectasia, July 10-11, 1997. Am J Med Genet 1998;76:269-73.
55. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990;265:8361-4.
56. Lastres P, Bellon T, Cabanas C, et al. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 1992;22:393-7.
57. Adam PJ, Clesham GJ, Weissberg PL. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. Biochem Biophys Res Commun 1998;247:33-7.
58. Conley BA, Smith JD, Guerrero-Esteo M, et al. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis 2000;153:323-35.
59. Raab U, Lastres P, Arevalo MA, et al. Endoglin is expressed in the chicken vasculature and is involved in angiogenesis. FEBS Lett 1999;459:249-54.
60. Jacobson BS. Hereditary hemorrhagic telangiectasia: a model for blood vessel growth and enlargement. Am J Pathol 2000;156:737-42.
61. Lastres P, Letamendia A, Zhang H, et al. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 1996;133:1109-21.
62. Caniggia I, Taylor CV, Ritchie JW, et al. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 1997;138:4977-88.
63. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 1999;274:584-94.
64. Yamashita H, Ichijo H, Grimsby S, et al. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. J Biol Chem 1994;269:1995-2001.
65. Letamendia A, Lastres P, Botella LM, et al. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem 1998;273:33011-9.
66. Pece N, Vera S, Cymerman U, et al. Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 1997;100:2568-79.
67. Lux A, Gallione CJ, Marchuk DA. Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms. Hum Mol Genet 2000;9:745-55.
68. Bourdeau A, Cymerman U, Paquet ME, et al. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 2000;156:911-23.
69. Bourdeau A, Faughnan ME, McDonald ML, et al. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 2001;158:2011-20.
70. Raab U, Velasco B, Lastres P, et al. Expression of normal and truncated forms of human endoglin. Biochem J 1999;339(Pt 3):579-88.
71. Paquet ME, Pece-Barbara N, Vera S, et al. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 2001;10:1347-57.
72. Shovlin CL, Hughes JM, Scott J, et al. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 1997;61:68-79.
73. McAllister KA, Baldwin MA, Thukkani AK, et al. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995;4:1983-5.
74. Yamaguchi H, Azuma H, Shigekiyo T, et al. A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb Haemost 1997;77:243-7.
75. Shovlin CL. Molecular defects in rare bleeding disorders: hereditary hemorrhagic telangiectasia. Thromb Haemost 1997;78:145-50.
76. Gallione CJ, Klaus DJ, Yeh EY, et al. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat 1998;11:286-94.
77. Shovlin CL. Supermodels and disease: insights from the HHT mice. J Clin Invest 1999;104:1335-6.
78. Vincent P, Plauchu H, Hazan J, et al. A third locus for hereditary hemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 1995;4:945-9.
79. Johnson DW, Berg JN, Gallione CJ, et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 1995;5:21-8.
80. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95.
81. Berg JN, Gallione CJ, Stenzel TT, et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 1997;61:60-7.
82. ten Dijke P, Yamashita H, Ichijo H, et al. Characterization of type I receptors for transforming growth factor-beta and activin. Science 1994;264:101-4.
83. Abdalla SA, Pece-Barbara N, Vera S, et al. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 2000;9:1227-37.
84. Klaus DJ, Gallione CJ, Anthony K, et al. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online. Hum Mutat 1998;12:137.
85. Jahnke V. Ultrastructure of hereditary telangiectasia. Arch Otolaryngol 1970;91:262-5.
86. Hashimoto K, Pritzker MS. Hereditary hemorrhagic telangiectasia. An electron microscopic study. Oral Surg Oral Med Oral Pathol 1972;34:751-68.
87. Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990;95:422-7.
88. Menefee MG, Flessa HC, Glueck HI, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). An electron microscopic study of the vascular lesions before and after therapy with hormones. Arch Otolaryngol 1975;101:246-51.
89. Shovlin CL, Scott J. Inherited diseases of the vasculature. Annu Rev Physiol 1996;58:483-507.
90. Sawabe M, Arai T, Esaki Y, et al. Three-dimensional organization of the hepatic microvasculature in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 2001;125:1219-23.
91. Childers RW, Ranniger K, Rabinowitz M. Intrahepatic arteriovenous fistula with pulmonary vascular obstruction in Osler-Rendu-Weber disease. Am J Med 1967;43:304-12.
92. Cooney T, Sweeney EC, Coll R, et al. "Pseudocirrhosis" in hereditary hemorrhagic telangiectasia. J Clin Pathol 1977;30:1134-41.
93. Daly JJ, Schiller AL. The liver in hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1976;60:723-6.
94. Halpern M, Turner AF, Citron BP. Hereditary hemorrhagic telangiectasia. An angiographic study of abdominal visceral angiodysplasias associated with gastrointestinal hemorrhage. Radiology 1968;90:1143-9.
95. Grollmus J, Hoff J. Multiple aneurysms associated with Osler-Weber-Rendu disease. Surg Neurol 1973;1:91-3.
96. Brant AM, Schachat AP, White RI. Ocular manifestations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Am J Ophthalmol 1989;107:642-6.
97. Fritzler MJ, Arlette JP, Behm AR, et al. Hereditary hemorrhagic telangiectasia versus CREST syndrome: can serology aid diagnosis? J Am Acad Dermatol 1984;10:192-6.
98. Ueda M, Abe Y, Fujiwara H, et al. Prominent telangiectasia associated with marked bleeding in CREST syndrome. J Dermatol 1993;20:180-4.
99. Lee JB, Ben Aviv D, Covello SP. The diagnostic quandary of hereditary hemorrhagic telangiectasia versus CREST syndrome. Br J Dermatol 2001;145:646-9.
100. Swanson DL, Dahl MV. Embolic abscesses in hereditary hemorrhagic telangiectasia. J Am Acad Dermatol 1991;24:580-3.
101. Kjeldsen AD, Oxhoj H, Andersen PE, et al. Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurologic symptoms in patients with hereditary hemorrhagic telangiectasia (HHT). J Intern Med 2000;248:255-62.
102. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-34.
103. Roman G, Fisher M, Perl DP, et al. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol 1978;4:130-44.
104. Willinsky RA, Lasjaunias P, Terbrugge K, et al. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 1990;32:207-10.
105. Byard RW, Schliebs J, Koszyca BA. Osler-Weber-Rendu syndrome: pathologic manifestations and autopsy considerations. J Forensic Sci 2001;46:698-701.
106. Berg JN, Guttmacher AE, Marchuk DA, et al. Clinical heterogeneity in hereditary hemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256-7.
107. McDonald JE, Miller FJ, Hallam SE, et al. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet 2000;93:320-7.
108. Kjeldsen AD, Brusgaard K, Poulsen L, et al. Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families. Am J Med Genet 2001;98:298-302.
109. Bernard G, Mion F, Henry L, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiologic, and hemodynamic studies of 11 cases. Gastroenterology 1993;105:482-7.
110. Martini GA. The liver in hereditary hemorrhagic teleangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal. Gut 1978;19:531-7.
111. Deviere J, Brohee D, Hiden M, et al. Hepatic telangiectasia and cirrhosis. J Clin Gastroenterol 1988;10:111-4.
112. Nyman U. Angiography in hereditary hemorrhagic telangiectasia. Acta Radiol Diagn (Stockh) 1977;18:581-92.
113. Thomas ML, Carty H. Hereditary hemorrhagic telangiectasia of the liver demonstrated angiographically. Acta Radiol Diagn (Stockh) 1974;15:433-8.
114. Razi B, Beller RM, Ghidoni J, et al. Hyperdynamic circulatory state due to intrahepatic fistula in Osler-Weber-Rendu disease. Am J Med 1971;50:809-15.
115. Amaris J, Duclos-Vallee JC, Bletry O, et al. Hereditary hemorrhagic telangiectasias with liver involvement and high cardiac output. Liver Transpl 2001;7:824-5.
116. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984;79:363-7.
117. Maruyama J, Watanabe M, Onodera S, et al. A case of Rendu-Osler-Weber disease with cerebral hemangioma, multiple pulmonary arteriovenous fistulas and hepatic arteriovenous fistula. Jpn J Med 1989;28:651-6.
118. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931-6.
119. Mukasa C, Nakamura K, Chijiiwa Y, et al. Liver failure caused by hepatic angiodysplasia in hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1998;93:471-3.
120. Burckhardt D, Stalder GA, Ludin H, et al. Hyperdynamic circulatory state due to Osler-Weber-Rendu disease with intrahepatic arteriovenous fistulas. Am Heart J 1973;85:797-800.
121. Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 1996;156:714-9.
122. Michaeli D, Ben Bassat I, Miller HI, et al. Hepatic telangiectasias and portosystemic encephalopathy in Osler-Weber-Rendu disease. Gastroenterology 1968;54:929-32.
123. Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment. J Gastroenterol Hepatol 2000;15:969-79.
124. Radtke WE, Smith HC, Fulton RE, et al. Misdiagnosis of atrial septal defect in patients with hereditary telangiectasia (Osler-Weber-Rendu disease) and hepatic arteriovenous fistulas. Am Heart J 1978;95:235-42.
125. Gothlin JH, Nordgard K, Jonsson K, et al. Hepatic telangiectasia in Osler's disease treated with arterial embolization. Report of 2 cases. Eur J Radiol 1982;2:27-30.
126. Danchin N, Thisse JY, Neimann JL, et al. Osler-Weber-Rendu disease with multiple intrahepatic arteriovenous fistulas. Am Heart J 1983;105:856-9.
127. Cloogman HM, DiCapo RD. Hereditary hemorrhagic telangiectasia: sonographic findings in the liver. Radiology 1984;150:521-2.
128. Livneh A, Langevitz P, Morag B, et al. Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. South Med J 1988;81:1047-9.
129. Bourgeois N, Delcour C, Deviere J, et al. Osler-Weber-Rendu disease associated with hepatic involvement and high output heart failure. J Clin Gastroenterol 1990;12:236-8.
130. Ball NJ, Duggan MA. Hepatolithiasis in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1990;114:423-5.
131. Ralls PW, Johnson MB, Radin DR, et al. Hereditary hemorrhagic telangiectasia: findings in the liver with color Doppler sonography. AJR Am J Roentgenol 1992;159:59-61.
132. Buscarini E, Buscarini L, Danesino C, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 1997;26:111-8.
133. Caselitz M, Wagner S, Chavan A, et al. Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut 1998;42:123-6.
134. McInroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol 1998;170:413-5.
135. Boillot O, Bianco F, Viale JP, et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 1999;116:187-92.
136. Trell E, Johansson BW, Linell F, et al. Familial pulmonary hypertension and multiple abnormalities of large systemic arteries in Osler's disease. Am J Med 1972;53:50-63.
137. Trotter JF, Suhocki PV, Lina JR, et al. Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolization. Am J Gastroenterol 1998;93:1569-71.
138. Spurny OM, Pierce JA. Cardiac output in systemic arteriovenous fistula complicated by heart failure. Am Heart J 1961;61:21-4.
139. Neumann UP, Knoop M, Langrehr JM, et al. Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation. Transpl Int 1998;1:323-6.
140. Pfitzmann R, Heise M, Langrehr JM, et al. Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. Transplantation 2001;72:237-41.
141. Gong B, Baken LA, Julian TM, et al. High-output heart failure due to hepatic arteriovenous fistula during pregnancy: a case report. Obstet Gynecol 1988;72:440-2.
142. Hillert C, Broering DC, Gundlach M, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation. Liver Transpl 2001;7:266-8.
143. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7.
144. Sussman EB, Sternberg SS. Hereditary hemorrhagic telangiectasia. A case with hepatocellular carcinoma and acquired hepatocerebral degeneration. Arch Pathol 1975;99:95-100.
145. Lande A, Bedford A, Schechter LS. The spectrum of arteriographic findings in Osler-Weber-Rendu disease. Angiology 1976;27:223-40.
146. Buscarini E, Buscarini L, Civardi G, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. AJR Am J Roentgenol 1994;163:1105-10.
147. Varma DG, Schoenberger SG, Kumra A, et al. Osler-Weber-Rendu disease: MR findings in the liver. J Comput Assist Tomogr 1989;13:134-5.
148. Goes E, Van Tussenbroeck F, Cottenie F, et al. Osler's disease diagnosed by ultrasound. J Clin Ultrasound 1987;15:129-31.
149. Ozdemir H, Ilgit ET, Konus O, et al. Hepatic color Doppler sonography for hereditary hemorrhagic telangiectasia. Abdom Imaging 1996;21:501-3.
150. Chou YH, Tiu CM, Hsu CC, et al. Hereditary hemorrhagic telangiectasia: hepatic lesions demonstrated with color Doppler and power Doppler sonography. Eur J Radiol 2000;34:52-6.
151. Ouchi K, Matsubara S, Mikuni J, et al. The radiologic presentation of Osler-Weber-Rendu disease of the liver. Am J Gastroenterol 1994;89:425-8.
152. Naganuma H, Ishida H, Niizawa M, et al. Hepatic involvement in Osler-Weber-Rendu disease: findings on pulsed and color Doppler sonography. AJR Am J Roentgenol 1995;165:1421-5.
153. Matsuo M, Kanematsu M, Kato H, et al. Osler-Weber-Rendu disease: visualizing portovenous shunting with three-dimensional sonography. AJR Am J Roentgenol 2001;176:919-20.
154. Lin JH, Yang PM, Tsang YM, et al. Sequential Doppler sonographic studies of embolization in a patient with hepatic involvement in hereditary hemorrhagic telangiectasia: correlation with angiographic findings. J Formos Med Assoc 1999;98:633-8.
155. Weik C, Greiner L. The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). Scand J Gastroenterol 1999;34:1241-6.
156. Vilgrain V, Lebrec D. Images in hepatology. Hepatic pseudotumor in Osler-Weber-Rendu disease. J Hepatol 1998;28:343.
157. Henderson JM, Liechty EJ, Jahnke RW. Case report. Liver involvement in hereditary hemorrhagic telangiectasia. J Comput Assist Tomogr 1981;5:773-6.
158. Lu DS, Lin J, Kadell BM. Congenital or idiopathic hepatic vascular malformations: CT findings. AJR Am J Roentgenol 1996;167:1155-7.
159. Baba Y, Ohkubo K, Hamada K, et al. Hyperintense basal ganglia lesions on T1-weighted images in hereditary hemorrhagic telangiectasia with hepatic involvement. J Comput Assist Tomogr 1998;22:976-9.
160. Suga K, Ishikawa Y, Matsunaga N, et al. Liver involvement in hereditary hemorrhagic telangiectasia: assessment with 99Tcm-phytate radionuclide angiography and 123I-IMP transrectal portal scintigraphy. Br J Radiol 2000;73:1115-9.
161. Gayed I, Dhekne R, Ford P, Moore W. False negative Tc-99m hepatobiliary scan in a patient with Osler-Weber-Rendu disease. Clin Nucl Med 1997;22:712-3.
162. Graham WP, Eiseman B, Pryor R. Hepatic artery aneurysm with portal vein fistula in a patient with familial hereditary telangiectasia. Ann Surg 1964;159:362-7.
163. Hisamatsu K, Ueeda M, Ando M, et al. Peripheral arterial coil embolization for hepatic arteriovenous malformation in Osler-Weber-Rendu disease; useful for controlling high output heart failure, but harmful to the liver. Intern Med 1999;38:962-8.
164. Whiting JH, Jr., Korzenik JR, Miller FJ, Jr., et al. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 2000;11:855-8.
165. Miller FJ, Jr., Whiting JH, Korzenik JR, et al. Caution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia. Radiology 1999;213:928-30.
166. Whiting JH, Jr., Morton KA, Datz FL, et al. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: case report. J Nucl Med 1992;33:260-2.
167. Brohee D, Franken P, Fievez M, et al. High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment. Arch Intern Med 1984;144:1282-4.
168. Derauf BJ, Hunter DW, Sirr SA, et al. Peripheral embolization of diffuse hepatic arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 1987;10:80-3.
169. Roman CF, Cha SD, Incarvito J, et al. Transcatheter embolization of hepatic arteriovenous fistula in Osler-Weber-Rendu disease-a case report. Angiology 1987;38:484-8.
170. Odorico JS, Hakim MN, Becker YT, et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transpl Surg 1998;4:483-90.
171. Rambusch EG, Chavan A, Harms CP, et al. Hereditary hemorrhagic telangiectasia with hepatic involvement and including gastric vessels. A case report. Vasa 1996;25:352-7.
172. Nikolopoulos N, Xynos E, Vassilakis JS. Familial occurrence of hyperdynamic circulation status due to intrahepatic fistulae in hereditary hemorrhagic telangiectasia. Hepatogastroenterology 1988;35:167-8.
173. Allison DJ, Jordan H, Hennessy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet 1985;1:595-9.
174. Bauer T, Britton P, Lomas D, et al. Liver transplantation for hepatic arteriovenous malformation in hereditary hemorrhagic telangiectasia. J Hepatol 1995;22:586-90.
175. Le Corre F, Golkar B, Tessier C, et al. Liver transplantation for hepatic arteriovenous malformation with high-output cardiac failure in hereditary hemorrhagic telangiectasia: hemodynamic study. J Clin Anesth 2000;12:339-42.
176. Cohen N, Gimson A, Scapa E, et al. Hereditary hemorrhagic telangiectasia and rapidly progressive parenchymal liver disease. J Clin Gastroenterol 1994;18:172-4.
177. Saxena R, Hytiroglou P, Atillasoy EO, et al. Coexistence of hereditary hemorrhagic telangiectasia and fibropolycystic liver disease. Am J Surg Pathol 1998;22:368-72.
178. Dines DE, Arms RA, Bernatz PE, et al. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1974;49:460-5.
179. Sharma VK, Howden CW. Gastrointestinal and hepatic manifestations of hereditary hemorrhagic telangiectasia. Dig Dis 1998;16:169-74.
180. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986;110:331-5.
181. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
182. Shimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997;26:343-50.